CN108778423A - 阿片类新生儿脱瘾综合征的治疗和预防 - Google Patents
阿片类新生儿脱瘾综合征的治疗和预防 Download PDFInfo
- Publication number
- CN108778423A CN108778423A CN201780015234.5A CN201780015234A CN108778423A CN 108778423 A CN108778423 A CN 108778423A CN 201780015234 A CN201780015234 A CN 201780015234A CN 108778423 A CN108778423 A CN 108778423A
- Authority
- CN
- China
- Prior art keywords
- opioid
- opioid antagonist
- brain
- naltrexol
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662276691P | 2016-01-08 | 2016-01-08 | |
| US62/276,691 | 2016-01-08 | ||
| PCT/US2017/012452 WO2017120417A1 (en) | 2016-01-08 | 2017-01-06 | Treatments and prevention of opioid neonatal abstinence syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108778423A true CN108778423A (zh) | 2018-11-09 |
Family
ID=59274434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201780015234.5A Pending CN108778423A (zh) | 2016-01-08 | 2017-01-06 | 阿片类新生儿脱瘾综合征的治疗和预防 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10925870B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3400066B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7061568B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108778423A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017206041B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3400066T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017120417A1 (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113573711A (zh) * | 2019-01-04 | 2021-10-29 | 伊瑟治疗公司 | 治疗药物或酒精依赖性的方法 |
| CN114096249A (zh) * | 2019-07-09 | 2022-02-25 | 奥瑞克索股份公司 | 用于鼻腔递送的药物组合物 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3066284A1 (en) * | 2018-04-09 | 2019-10-17 | Katana Pharmaceuticals, Inc. | Oxytocin compositions and methods of use |
| US20240325379A1 (en) * | 2021-07-06 | 2024-10-03 | Aether Therapeutics Inc. | Low-dose naltrexol and uses thereof |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4743601A (en) * | 2000-03-15 | 2001-09-24 | Wolfgang Sadee | Neutral antagonists and use thereof in treating drug abuse |
| DE602004009449T2 (de) * | 2003-07-25 | 2008-07-24 | Euro-Celtique S.A. | Behandlung von entzug |
| EP1817023A4 (en) * | 2004-11-16 | 2010-08-18 | Limerick Biopharma Inc | METHODS AND COMPOSITIONS FOR TREATING PAIN |
| CA2702680A1 (en) | 2007-10-18 | 2009-04-23 | Aiko Biotechnology | Combination analgesic employing opioid and neutral antagonist |
| US8748448B2 (en) | 2007-10-18 | 2014-06-10 | Aiko Biotechnology | Combination analgesic employing opioid agonist and neutral antagonist |
| WO2009079489A1 (en) * | 2007-12-17 | 2009-06-25 | The Ohio State University Research Foundation | Methods for screening of opioid receptor neutral antagonists and inverse agonists and uses thereof |
| WO2010065930A1 (en) * | 2008-12-04 | 2010-06-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating or preventing narcotic withdrawal symptoms |
-
2017
- 2017-01-06 EP EP17736392.6A patent/EP3400066B1/en active Active
- 2017-01-06 AU AU2017206041A patent/AU2017206041B2/en active Active
- 2017-01-06 DK DK17736392.6T patent/DK3400066T3/da active
- 2017-01-06 WO PCT/US2017/012452 patent/WO2017120417A1/en not_active Ceased
- 2017-01-06 CN CN201780015234.5A patent/CN108778423A/zh active Pending
- 2017-01-06 JP JP2018535324A patent/JP7061568B2/ja active Active
- 2017-01-06 US US16/068,593 patent/US10925870B2/en active Active
-
2021
- 2021-02-22 US US17/180,945 patent/US12161641B2/en active Active
-
2024
- 2024-12-06 US US18/972,105 patent/US20250177379A1/en active Pending
Non-Patent Citations (4)
| Title |
|---|
| DEBELAK ET AL: "Buprenorphine+naloxone", 《THE AMERICAN JOURNAL ON ADDICTIONS》 * |
| S.L. WIEGAND, ET AL.: "Buprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy", 《OBSTET GYNECOL.》 * |
| 国家食品药品监督管理总局执业药师资格认证中心: "《药学专业知识(1)第七版2015》", 28 February 2015 * |
| 钱之玉: "《药理学4版》", 31 August 2015, 中国医药科技出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113573711A (zh) * | 2019-01-04 | 2021-10-29 | 伊瑟治疗公司 | 治疗药物或酒精依赖性的方法 |
| CN114096249A (zh) * | 2019-07-09 | 2022-02-25 | 奥瑞克索股份公司 | 用于鼻腔递送的药物组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3400066B1 (en) | 2021-07-28 |
| EP3400066A4 (en) | 2019-06-26 |
| US20250177379A1 (en) | 2025-06-05 |
| WO2017120417A1 (en) | 2017-07-13 |
| JP7061568B2 (ja) | 2022-04-28 |
| EP3400066A1 (en) | 2018-11-14 |
| AU2017206041B2 (en) | 2022-07-28 |
| JP2019501194A (ja) | 2019-01-17 |
| US10925870B2 (en) | 2021-02-23 |
| US12161641B2 (en) | 2024-12-10 |
| DK3400066T3 (da) | 2021-10-18 |
| US20210205296A1 (en) | 2021-07-08 |
| AU2017206041A1 (en) | 2018-07-26 |
| CA3010609A1 (en) | 2017-07-13 |
| US20190015406A1 (en) | 2019-01-17 |
| NZ744112A (en) | 2025-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12161641B2 (en) | Treatments and prevention of opioid neonatal abstinence syndrome | |
| KR102271048B1 (ko) | 콜히친의 서방형 제형 및 이의 이용 방법 | |
| BRPI0707044B1 (pt) | comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais | |
| KR20240023691A (ko) | 다낭성 난소 증후군을 치료하기 위한 방법 및 조성물 | |
| RU2696563C9 (ru) | Композиционный препарат, включающий слой пленочного покрытия, содержащий активный ингредиент | |
| TWI483738B (zh) | 具有改良之味道遮蔽性的擠出物 | |
| JP2016172752A (ja) | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 | |
| JP2022501320A (ja) | 抗血小板剤と胃酸分泌阻害剤を含む医薬組成物 | |
| WO2021171237A1 (en) | Pharmaceutical composition for oral administration | |
| JP2018039831A (ja) | 排尿頻度を減少させるための医薬製剤およびその使用の方法 | |
| EP3302458B1 (en) | Methods of preventing and treating autoimmunity | |
| WO2009126606A2 (en) | Regression of established atherosclerotic plaques, and treating sudden-onset asthma attacks, using parp inhibitors | |
| KR20160011205A (ko) | 히드로코티손을 포함하는 조성물 | |
| EP3949955A1 (en) | Pharmaceutical composition comprising esomeprazole or pharmaceutically acceptable salt thereof and having double-release profile | |
| HK1260764A1 (en) | Treatments and prevention of opioid neonatal abstinence syndrome | |
| CN115702935B (zh) | 一种氯雷他定药物组合物及其制备方法 | |
| TWI775408B (zh) | 用以治療與嗜中性白血球激活失調及趨化相關之疾病的方法 | |
| WO2017059726A1 (zh) | 癸酸甘油三酯类化合物在制备治疗多囊卵巢综合症药物中的应用 | |
| JP2018529711A (ja) | 排尿の頻度を低減するための組成物、ならびにその作製および使用方法 | |
| WO2018192469A1 (en) | Inhibitors of fabp4 and methods of treating arthritis | |
| US20240325379A1 (en) | Low-dose naltrexol and uses thereof | |
| JP2010013481A (ja) | アムロジピン含有粒子およびそれからなる口腔内崩壊錠 | |
| HK40111880A (en) | Low-dose naltrexol and uses thereof | |
| RU2343908C1 (ru) | Средство для профилактики и лечения алкоголизма и способ его применения | |
| JP2018538279A (ja) | 排尿の頻度を低減するための組成物、ならびにその作製および使用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1260764 Country of ref document: HK |
|
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181109 |